Global Epigenetic Market Growth (Status and Outlook) 2024-2030
According to this study, the global Epigenetic market size will reach US$ 11100 million by 2030.
Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
This report presents a comprehensive overview, market shares, and growth opportunities of Epigenetic market by product type, application, key players and key regions and countries.
Segmentation by product type: Reagents Kits Instruments Enzymes Services
Segmentation by Application: Academic Research Institutes Biotechnology Companies Biopharmaceutical Companies Diagnostic Companies
This report also splits the market by region: United States China Europe Other regions: Japan South Korea Southeast Asia Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Illumina Qiagen Abcam Merck & Co Sigma-Aldrich New England Biolabs Thermo Fisher Scientific Diagenode Active Motif Roche Diagnostics Eisai Novartis
Please note: The report will take approximately 2 business days to prepare and deliver.
*This is a tentative TOC and the final deliverable is subject to change.*